Trump admin may reclassify marijuana: Would that make it legal in the US?
cnyhomepage.com -- Sunday, August 17, 2025, 3:26:01 PM Eastern Daylight Time
Categories: Foreign Policy & International Relations, Media Coverage & Press Relations
(NEXSTAR) -- At the end of last year, it seemed that marijuana could be rescheduled in the U.S. That idea came screeching to a halt when proceedings were put on pause in January.
There were early hopes that the then-incoming Trump administration would get the ball rolling, but that didn't immediately materialize either. On Monday, however, President Donald Trump confirmed his administration is "looking at" reclassifying marijuana as a less dangerous drug.
"We're looking at reclassification, and we'll make a determination over, I'd say, the next few weeks," Trump said during a press conference, The Hill reported.
Marijuana is a Schedule I drug, but the latest efforts, launched under the Biden administration, would put it as a Schedule III drug. The process of rescheduling marijuana -- or trying to -- has historically played out over years and even decades, Paul Armentano, the deputy director for the National Organization for the Reform of Marijuana Laws (NORML), previously told Nexstar.
It's difficult to say how fast efforts could play out now, but Heather Trela, director of operations and fellow at the Rockefeller Institute, told Nexstar in April that they could be fueled by Trump.
"If President Trump made this a priority, I think this would move," she explained.
If it does happen, it would be the largest DEA policy change in more than 50 years, but you may not notice an immediate impact.
If marijuana is rescheduled, will it become legal nationwide?
The short, immediate answer is no.
As a Schedule I controlled substance, marijuana is considered by the DEA to be it without a "currently accepted medical use" and has a "high potential for abuse." Heroin and LSD are also Schedule I drugs.
The Department of Health and Human Services recommended in 2023 that marijuana be reclassified as a Schedule III drug. Ketamine and some anabolic steroids are Schedule III substances, which have a "moderate to low potential for physical and psychological dependence."
Even if marijuana is rescheduled, it would still be a controlled substance that's subject to federal rules and regulations. More importantly, rescheduling does not decriminalize marijuana or make it legal for recreational use on the federal level.
Instead, the medical uses of cannabis would be recognized, and federal regulators would acknowledge it has less potential for abuse than some of the nation's most dangerous drugs. It would also become easier for marijuana research to be conducted.
Companies could see a cut in the federal taxes they pay, too. Currently, businesses involved in "trafficking" in marijuana or any other Schedule I or II drug can't deduct rent, payroll or various other expenses that other businesses can write off. Industry groups say the tax rate often ends up at 70% or more.
As a Schedule III drug, marijuana would still be regulated by the DEA and the thousands of dispensaries nationwide would have to register with the agency, just as pharmacies do. Critics say this would come with strict reporting requirements, something dispensaries may despise and the DEA may not be ready for.
The immediate effect of rescheduling on the nation's criminal justice system would also likely be more muted, since federal prosecutions for simple possession have been fairly rare in recent years.
Then there's the United States' international treaty obligations, chief among them the 1961 Single Convention on Narcotic Drugs, which requires the criminalization of cannabis. In 2016, during the Obama administration, the DEA cited the U.S.' international obligations and the findings of a federal court of appeals in Washington in denying a similar request to reschedule marijuana.
Where do state efforts to legalize marijuana stand?
More than three dozen states have legalized some form of medical marijuana already. Nearly half have legalized it for recreational use among adults.
Meanwhile, some states that have already legalized marijuana have seen efforts to roll back voter-approved laws or repeal them. That includes Ohio, where some have been trying to rewrite the recreational marijuana law voters approved two years ago.
Other states have made adjustments to aspects of the law, like lowering legal potency levels, Trela said. In some cases, like Virginia, lawmakers have been unable to pass a sales bill, so while possessing cannabis is legal, there is nowhere in the state to legally purchase it.
The federal government could, however, turn over the decision of legalization to the states, as it did during prohibition.
A bill introduced in the House earlier this year could do just that. The bipartisan STATES 2.0 Act would "end the federal prohibition of cannabis and allow states to determine their own cannabis policies." It has been referred to the House Committee on Energy and Commerce.
The Associated Press contributed to this report.
Sign Our PetitionThe discussion surrounding the potential reclassification of marijuana in the United States has gained significant traction, particularly with the recent remarks from former President Donald Trump indicating that his administration is "looking at" the matter. This moment presents a critical juncture in the long-standing debate over cannabis, touching upon foundational issues of justice, public health, and economic equity. Understanding the historical context of marijuana prohibition is essential when evaluating the implications of reclassification, which can lead to broader conversations about drug policy reform and social justice.
Historically, the criminalization of marijuana can be traced back to the early 20th century, when it became associated with racial and socioeconomic biases. Figures such as Harry Anslinger, the first commissioner of the Federal Bureau of Narcotics, fueled anti-marijuana sentiment by linking cannabis use to the perceived threats posed by marginalized communities. This stigma has persisted, resulting in disproportionate arrest rates among people of color, despite similar usage rates across demographics. The ongoing war on drugs has perpetuated systemic injustices that have devastated communities, disproportionately affecting those already marginalized in society. In this light, discussions about reclassifying marijuana can be seen as a call for rectifying historical injustices and moving toward a more equitable society.
From a public health perspective, the potential reclassification of marijuana from Schedule I to Schedule III could offer a significant shift in how cannabis is perceived and regulated. Schedule I classification implies that marijuana has no accepted medical use, placing it in the same category as heroin and LSD. However, extensive research has demonstrated the therapeutic benefits of cannabis for various medical conditions, including chronic pain, epilepsy, and mental health disorders. By acknowledging its medical use, the government could enhance access for patients who rely on cannabis for relief. This reclassification could pave the way for more comprehensive research into the efficacy and safety of marijuana, enabling a more informed public health dialogue about its use.
Economically, the implications of reclassifying marijuana are profound. As it stands, businesses engaged in marijuana production and distribution face exorbitant tax burdens due to their classification as Schedule I substances. They are unable to deduct standard business expenses, resulting in tax rates exceeding 70% for some. If marijuana were to be reclassified to Schedule III, these businesses could benefit from fairer tax treatment, potentially fostering growth within the industry. Additionally, states that have legalized marijuana have witnessed significant economic benefits, including job creation, increased tax revenue, and reduced law enforcement costs. Thus, reclassification could not only support a burgeoning industry but also stimulate local economies and contribute positively to state budgets.
Despite these potential benefits, it is crucial to recognize that reclassification does not equate to full legalization. Marijuana would still be subject to federal regulations, and possession would remain illegal under federal law. This distinction underscores the urgent need for comprehensive federal legalization that addresses not only the economic and medicinal aspects but also the social injustices inherent in the current legal framework. Advocates for legalization argue that a more equitable approach must include provisions for expunging criminal records of those convicted of non-violent cannabis offenses, addressing the racial disparities that have characterized marijuana arrests.
In conclusion, the conversation surrounding the reclassification of marijuana provides an opportunity to engage in a broader dialogue about drug policy reform, social justice, and public health. As we move forward, it is imperative to advocate for a comprehensive approach that not only acknowledges the medicinal and economic benefits of marijuana but also seeks to rectify the injustices of the past. Bringing these points to discussions with opponents of reform can help illuminate the multifaceted nature of this issue, fostering a more informed and compassionate discourse. In doing so, we can work toward a future that prioritizes equity, justice, and well-being for all.
The ongoing debate surrounding the reclassification of marijuana in the United States encapsulates a broader struggle over drug policy, social justice, and public health. Historically, marijuana has been classified as a Schedule I substance since the Controlled Substances Act of 1970, branding it alongside drugs like heroin and LSD, which are recognized as having high potential for abuse. This classification has not only hindered research into the medical benefits of cannabis but has also perpetuated a criminal justice system that disproportionately targets marginalized communities. As discussions of reclassification resurface, particularly under the Trump administration's recent acknowledgment of this issue, it is crucial to consider the potential ramifications and the actions that can be taken to advocate for a more equitable drug policy.
The idea of rescheduling marijuana from Schedule I to Schedule III is significant, but it is essential to clarify what this change would entail. While moving to Schedule III could acknowledge marijuana's medicinal benefits and reduce federal tax burdens for cannabis businesses, it would not decriminalize the substance nor make it legal for recreational use at the federal level. This nuance is critical in conversations with individuals who may view reclassification as a panacea for the issues surrounding cannabis use. It is also crucial to recognize that even if marijuana is rescheduled, the federal government would continue to impose regulations that could restrict access and oversight. Thus, advocates for reform must be vigilant and prepared to push for more substantial changes that address the systemic inequities embedded in drug laws.
In the context of social justice, the reclassification of marijuana presents an opportunity to rectify the historical injustices associated with its prohibition. The War on Drugs has disproportionately affected communities of color, leading to incarceration rates that are alarmingly disproportionate to the general population. As marijuana legalization efforts continue to gain traction at the state level—where many states have already legalized it for recreational use—activists must work to ensure that any federal changes include provisions for restorative justice. This could mean expunging criminal records for cannabis-related offenses, providing economic opportunities for those negatively impacted by past policies, and ensuring that the benefits of a legalized market are equitably distributed.
As concerned citizens and advocates, we must engage our communities and encourage dialogue around cannabis policy. Hosting town hall meetings, writing to elected officials, and utilizing social media platforms can help raise awareness about the importance of reclassification and the need for comprehensive reform. Moreover, building coalitions with organizations that focus on drug policy reform, social justice, and public health can amplify our voices. Educating ourselves and others about the economic benefits of legalization—such as job creation, increased tax revenue, and reduced law enforcement costs—can also provide compelling arguments for shifting the narrative around marijuana use.
Ultimately, the conversation surrounding the future of marijuana in the U.S. is not simply a matter of reclassification. It is a reflection of broader societal values regarding health, justice, and equality. As discussions evolve, we must approach the topic with a critical eye, advocating for policies that not only recognize marijuana's medical potential but also dismantle the harmful legacies of its prohibition. By taking proactive steps to engage in advocacy and education, we can contribute to a more just and equitable approach to cannabis policy, ensuring that it aligns with the principles of social equity and public health that should guide our society.
Analyzing the potential reclassification of marijuana from a left-wing perspective presents an opportunity for advocacy and action in support of drug policy reform, social justice, and public health. Here’s a detailed list of ideas and actions that individuals can take to influence this movement:
### What Can We Personally Do About This?
1. **Educate Yourself and Others**: - Stay informed about the implications of marijuana reclassification and its potential effects on health, justice, and the economy. - Share articles, infographics, and studies that highlight the benefits of legalization and medical use.
2. **Engage in Advocacy**: - Participate in local or national campaigns promoting marijuana reform. - Join organizations that focus on drug policy reform, such as the National Organization for the Reform of Marijuana Laws (NORML).
3. **Support Local Efforts**: - Volunteer for or donate to local advocacy groups that focus on cannabis legalization and social equity in the cannabis industry.
### Exact Actions to Take
1. **Petition Initiatives**: - Sign and promote petitions that call for the reclassification of marijuana. For example, visit websites like Change.org or Care2 to find existing petitions. - Consider creating your own petition targeting specific issues, such as expunging records for past marijuana offenses.
2. **Contact Your Representatives**: - Write to your elected officials to express your support for marijuana reclassification. Here are some key contacts:
**U.S. Senators**: - **Chuck Schumer** (D-NY) - Email: schumer.senate.gov/contact/email-chuck - Mailing Address: 322 Hart Senate Office Building, Washington, DC 20510 - **Ron Wyden** (D-OR) - Email: wyden.senate.gov/contact - Mailing Address: 221 Dirksen Senate Office Building, Washington, DC 20510
**U.S. Representatives**: - **Pramila Jayapal** (D-WA) - Email: jayapal.house.gov/contact - Mailing Address: 2233 Rayburn House Office Building, Washington, DC 20515
When writing, use points such as: - The economic benefits of marijuana legalization. - The social justice implications, especially regarding the disproportionate impact of current marijuana laws on marginalized communities. - The need for scientific research on cannabis and its medical uses.
3. **Engage on Social Media**: - Use platforms like Twitter, Instagram, and Facebook to raise awareness about marijuana reclassification. Share facts, personal stories, and calls to action using relevant hashtags like #LegalizeIt, #MarijuanaReform, and #CannabisCommunity. - Tag your elected officials and encourage dialogue on their platforms.
4. **Organize Community Events**: - Host or participate in community forums, webinars, or town hall meetings to discuss marijuana policy reform. - Create space for people to share their experiences and advocate for change collectively.
5. **Participate in Public Comments**: - Stay alert for opportunities to provide public comments during hearings or consultations regarding drug policy. The DEA and other governmental bodies often seek public input on regulations.
6. **Support Local Cannabis Businesses**: - If you live in a state where marijuana is legal, support local dispensaries that advocate for social equity within the cannabis industry. Choose to shop at businesses that give back to the community or engage in fair practices.
### What to Say
When reaching out to representatives or participating in advocacy efforts, consider including the following points in your correspondence:
- **Support for Reclassification**: "I urge you to support the reclassification of marijuana to Schedule III. This change would acknowledge its medical benefits and reduce the punitive tax burden on legitimate businesses." - **Social Justice**: "Current marijuana laws disproportionately impact communities of color. Reclassification is a step towards correcting these injustices and expunging records for non-violent offenses."
- **Scientific Research**: "We need to facilitate research on cannabis to explore its medical uses fully. Rescheduling could open doors for studies that could benefit many patients."
By taking these actions, you can contribute to a larger movement advocating for sensible drug policies that prioritize public health, economic opportunity, and social equity.